Key findings from the 48-week study include: Significant Weight Loss: Subjects receiving pemvidutide achieved mean weight losses of 10.3%, 11.2%, and 15.6% at the 1.2 mg, 1.8 mg, and 2.4 mg doses, respectively, compared to 2.2% for placebo
Utilities Utilities are used to quantify the perception of health for an individuals health state, and range from 0 (death) to 1 (perfect health)
GLP-1 is a hormone produced by the intestines in response to food intake
The Impact of GLP-1-Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta-Analysis
The microRNA-10b targeted therapeutic, TTX-MC138, is effective in preclinical pancreatic adenocarcinoma
You also have those pills for men, we call those things, oh my goodness, for erections